An interventional study of Education program in Colorectal Cancer, sponsored by Krankenhaus Nordwest. Recruiting at 2 sites in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-03-06.
Sponsored by Krankenhaus Nordwest · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 353 studies in Colorectal Neoplasms with a site in Germany — 63 open to participants now, 90 under way, 19 of them phase 3. Colorectal Neoplasms · Germany.
Among the 353 studies in Colorectal Neoplasms with a site in Germany, this one is the 158th largest by planned enrollment of the 290 interventional ones that give a count, is one of 16 that started in 2015, is one of 34 with no phase, reaches primary completion later than 11 of the 89 other live ones, and was the 168th registered.
6,556 studies on the registry are indexed under Colorectal Neoplasms; 1,664 are open to participants now.
Browse Colorectal Neoplasms studies →63 of the 353 studies in Colorectal Neoplasms with a site in Germany are open now. Recruiting first, the newest first:
AbbVie · Sites in Germany, United States, Belgium and 8 more countries
Ages 18+
EMD Serono Research & Development Institute, Inc. · Sites in Germany, United States, Argentina and 16 more countries
Ages 18+
University of Regensburg · Sites in Germany
Ages 18+ · Healthy volunteers
Incyte Corporation · Sites in Germany, United States, Argentina and 19 more countries
Ages 18+
Bristol-Myers Squibb · Sites in Germany, United States, Argentina and 22 more countries
Ages 18+
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 1,179 Colorectal Neoplasms studies recruiting now, 762 (65%) set no upper age limit and 264 (22%) stop at 75 or younger; 48 take children under 18; 123 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
353 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 91 · Phase 2 129 · Phase 3 78 · Phase 4 5
First in 1991; this study’s year is marked. 16 started in 2015.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 138 is above the median of 76 across 4,811 interventional studies indexed under Colorectal Neoplasms.
Median enrollment 169 across the 290 interventional studies, 542 across the 57 observational. Of the 228 that completed or were terminated, 79 (35%) have results posted.
This tab as a report to print or save as PDF → With an account.
219 of 353 have an industry lead sponsor. The 10 most frequent:
Krankenhaus Nordwest is the lead sponsor of 14 studies on the registry; 2 are open to participants now.
Krankenhaus Nordwest has 1 study filed under Colorectal Neoplasms — fewer than ten, so there is no comparison to draw.
26 of the studies in Colorectal Neoplasms with a site in Germany that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05008809Phase 3Dominik Paul ModestPost-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418) | 2027-11 |
| NCT04486378BioNTech SEA Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer | 2026-11 |
| NCT05991102Charite University, Berlin, GermanyAmplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With TAS-102 (Lonsurf) and Bevacizumab in Refractory Metastatic Colorectal Cancer | 2026-11 |
| NCT06607458Delcath Systems Inc.Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease | 2026-12 |
| NCT01789229Medical University of ViennaEstablishment of a Tumor Bank for Tissue Samples | 2026-12 |
Add all 26 to your calendar (.ics) → With an account.
Among the 353 studies in Colorectal Neoplasms with a site in Germany, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Patients with colorectal cancer prior to stoma surgery are randomized to different preoperative education programs: (a) specific preoperative education, (b) standard preoperative education. Outcome measures are quality of life, period of hospitalization and complication rates.
The present study is initiated to evaluate quality of life, period of hospitalization and complication rates in patients with colorectal cancer receiving treatment with stoma surgery. Prior to surgery patients are randomized to different preoperative education programs. In Arm A patients receive a new specific education program (Krankenhaus Nordwest concept) conducted by a specialized therapist (stoma-therapist). In Arm B patients receive the standard preoperative education program. Standardized questionnaires are used to evaluate quality of life and period of hospitalization at baseline and four weeks after surgery in Arm A vs. Arm B
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A scale of how much an illness limits everyday activity. For people being assessed to join a study, scores run from 0 (fully active) to 4; lower is more active.
Studies most often ask for 0–1 or 0–2. Your doctor gives the score; the WHO scale uses the same steps. The full scale also has 5, which records death.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
ECOG performance status
A scale of how much an illness limits everyday activity. For people being assessed to join a study, scores run from 0 (fully active) to 4; lower is more active.
Studies most often ask for 0–1 or 0–2. Your doctor gives the score; the WHO scale uses the same steps. The full scale also has 5, which records death.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
specific preoperative education program realised by a specialized stoma-therapist containing individualized information on material maintenance, hygiene, nutrition, complications, activities of daily life and occupation
Other: Education program
standard preoperative education program administered by a surgeon containing information on surgery, outcome, risks and alternatives
Other: Education program
Verbal education prior tu surgery administered to all patients in order to inform about the surgery and outcomes
Quality of life
Quality of life is assessed with EORTC QLQ-30 and EORTC QLQ-CR 29 at baseline, 9-15 days after surgery and 4 weeks after surgery. An improvement in Arm A is characterized by 10 points
Time frame: 9-15 days after surgery
Quality of Life
Quality of life is assessed with EORTC QLQ-30 and EORTC QLQ-CR 29 at baseline, 9-15 days after surgery and 4 weeks after surgery. An improvement in Arm A is characterized by 10 points
Time frame: 4 weeks after surgery
Period of hospitalization
Time frame: 9-15 days after surgery, 4 weeks after surgery
Complication rates
Time frame: 9-15 days after surgery, 4 weeks after surgery
Plan to share: No — No IPD will be shared
No publications or documents are linked to this record.
Started Nov 2015 (actual). Primary completion is estimated for Jun 2025, 115 months after the start.
Of 900 non-industry interventional studies with no phase under Colorectal Neoplasms, half reached primary completion within 32 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 61. This study's planned 115 months is above that.
Counting every sponsor, half of 958 studies reached it within 31 months; a quarter within 14 and three quarters within 60.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Krankenhaus Nordwest